HLA Lab Director
King Hussein Cancer Center, Jordan
After many years of study and work, nationally and internationally, Dr Ahmad gained a lot of experience in Stem Cell research and clinical applications as well Organs Transplantation Immunology. His trip started by finishing his master’s degree in Hematology from the University of Jordan and later a PhD on the reconstitution of T lymphocytes after bone marrow transplantation, from the University of Regensburg - Germany. After working as university Assistant Professor in many universities in Jordan, he started working in the Center of Innovation at the Canadian Blood Services in Ottawa - Canada. At that position Dr Ahmad worked on expanding hematopoietic stem cells using different platforms aiming to boost BMT clinical trials. Later he joined the Department of Cellular Therapy and Applied Genomics at the King Hussien Cancer Center as Clinical Scientist to lead the clinical BMT services and help in saving many cancer patients at KHCC.
Dr Ahmad later started his Fellowship on transplantation immunology at the Alberta Precision Laboratories (APL), in Calgary - Canada, where he gained his training on solid organs transplantation including heart, kidney, lung, intestine, and islets transplants from living and deceased donors. In addition, selecting best donors for allogeneic BMT. After finishing the fellowship and passing the Board exams of the ASHI, he worked as the Associated Director of human leukocyte antigen (HLA) laboratory at the University of Texas Southwestern Medical Center (UTSW), USA. Later Dr Ahmad was recruited by KHCC again to lead both the BMT Laboratory and HLA Laboratory as Section Head and Senior Clinical Scientist. The latest achievement for Dr Ahmad was establishing the first chimeric antigen receptors T lymphocytes (CAR-T) production in Jordan that initiated by KHCC for the treatment of Jordanian refractory lymphoma patients, that was approved by the Jordan Food & Drug Administration (JFDA).